Ocugen, Inc. (OCGN)
1.315
-0.02
(-1.13%)
USD |
NASDAQ |
Sep 01, 14:15
Ocugen Cash from Operations (Annual) : -56.96M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -56.96M |
| December 31, 2024 | -42.14M |
| December 31, 2023 | -62.05M |
| December 31, 2022 | -60.08M |
| December 31, 2021 | -47.94M |
| December 31, 2020 | -14.71M |
| December 31, 2019 | -16.89M |
| Date | Value |
|---|---|
| December 31, 2018 | -11.63M |
| December 31, 2017 | -23.02M |
| December 31, 2016 | -25.74M |
| December 31, 2015 | -30.03M |
| December 31, 2014 | -18.40M |
| December 31, 2013 | -15.28M |
| December 31, 2012 | -12.23M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Biogen, Inc. | 2.205B |
| Gilead Sciences, Inc. | 10.02B |
| MannKind Corp. | 18.26M |
| Vertex Pharmaceuticals, Inc. | 3.631B |